Eli Lilly and Company (NYSE: LLY) is reportedly in advanced talks to acquire gene editing biotech Verve Therapeutics Inc.

The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, aiming to ...

Obesity is a global health crisis with profound clinical and societal consequences, contributing to increased risks of chronic illness and related mortality.1 Despite being recognised as a disease by ...

Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the Danish ...

A third-party health insurance payer can proceed as a class in a racketeering lawsuit against Takeda Pharmaceuticals Co. and Eli Lilly & Co., a federal appeals panel ruled Monday.

Lilly the service dog embraced her new owner, 30-year decorated army veteran and Kansas City native, First Sgt. Michael Gainey.

Eli Lilly employees join forces for community service with Connecting Hearts at Home initiative in central Indiana, ...

Archaeologists discover evidence of Roanoke colonists' fate after abandoning settlement Gina Gershon: ‘People like to cast me as a hardcore, motorcycle-riding, lesbian, man-killing demon’ "We're done" ...

The biggest on-court criticism that Chicago Sky superstar Angel Reese has dealt with to this point in her professional basketball career related to her struggle ...

U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...

The stock's fall snapped a six-day winning streak.